Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.
- NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_assertion wasGeneratedBy ECO_0000218 NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.
- NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_assertion wasDerivedFrom ctd_human-20130708 NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.
- NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_assertion SIO_000772 15248218 NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.
- NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_assertion evidence source_evidence_curated NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.
- NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_assertion description "[Patients who were either heterozygous or homozygous for CYP2C19*2 had a significantly lower risk of developing premature ovarian failure (relative risk 0.10; 95% confidence interval 0.02-0.52), after adjustment for age and total number of cyclophosphamide pulses received.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.
- ctd_human-20130708 importedOn "2013-07-24" NP13447.RAtfEut3KlzH_j7lQ59xvHF732sWh-PTnlyEeQ7829DPI130_provenance.